Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Metastatic Head and Neck Squamous Cell Carcinoma; Metastatic Hypopharyngeal Squamous Cell Carcinoma; Metastatic Lary ngeal Squamous Cell Carcinoma; Metastatic Lip and Oral Cavity Carcinoma; Metastatic Nasal Cavity Squamous Cell Carcinoma; Metastatic Nasopharyngeal Squamous Cell Carcinoma; Metastatic Pharyngeal Squamous Cell Carcinoma; Metastatic Sinonasal Squamous Cell Carci noma; Patholog...
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials